Can Fite BioPharma : Report Of Foreign Private Issuer - Form 6-K -November 22, 2023 at 04:18 pm EST

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549



FORM 6-K



Report of Foreign Private Issuer
...

Related Keywords

Israel ,Washington ,United States ,American ,Kiryat Matalon ,Motti Farbstein ,Commission File Number ,Securities Exchange ,Company American Depositary Shares ,Exchange Commission ,Hc Wainwright Co ,Fite Biopharma Ltd ,Company Adss ,Foreign Private Issuer ,Securities Exchange Act ,Registration Statements ,Can Fite Biopharma ,American Depositary Shares ,Inducement Letter ,Existing Warrants ,Closing Date ,Placement Agent ,New Warrants ,Placement Agent Warrants ,New Warrant Shares ,Resale Registration Statement ,New Warrant ,Variable Rate Transaction ,Securities Act ,Fundamental Transaction ,Black Scholes Value ,Private Securities Litigation Reform Act ,Executive Officer ,Markets ,